Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Isolated cerebral mucormycosis associated with intravenous drug use.

PMID: 33067115
Journal: JOURNAL DE MYCOLOGIE MEDICALE
Year: 2020
Reference: J Mycol Med. 2020 Dec;30(4):101046. doi: 10.1016/j.mycmed.2020.101046. Epub 2020 Oct 6.
Impact factor: 1.56
Publication type: Letter or abstract
Authors: Dura-Miralles, X, Escola-Verge, L, Moreno, D, Martinez-Ricarte, F, Lung, M, Fernandez-Hidalgo, N, Auger, C, Martin-Gomez, M-T et al.
DOI: 10.1016/j.mycmed.2020.101046

Isolated cerebral mucormycosis associated with intravenous drug use.

PMID: 33067115
Journal: JOURNAL DE MYCOLOGIE MEDICALE
Year: 2020
Reference: J Mycol Med. 2020 Dec;30(4):101046. doi: 10.1016/j.mycmed.2020.101046. Epub 2020 Oct 6.
Impact factor:
Publication type: Letter or abstract
Authors: Auger, C; Dura-Miralles, X; Escola-Verge, L; Fernandez-Hidalgo, N; Lung, M; Martin-Gomez, M-T; Martinez-Ricarte, F; Moreno, D et al.
DOI: 10.1016/j.mycmed.2020.101046

Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan.

PMID: 31943195
Journal: HEADACHE
Year: 2020
Reference: Headache. 2020 Mar;60(3):576-588. doi: 10.1111/head.13731. Epub 2020 Jan 13.
Impact factor: 4.041
Publication type: Paper in international publication
Authors: Kudrow, David, Krege, John H, Hundemer, Hans P, Berg, Paul H, Khanna, Rashna, Ossipov, Michael H, Pozo-Rosich, Patricia et al.
DOI: 10.1111/head.13731

Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan.

PMID: 31943195
Journal: HEADACHE
Year: 2020
Reference: Headache. 2020 Mar;60(3):576-588. doi: 10.1111/head.13731. Epub 2020 Jan 13.
Impact factor:
Publication type: Paper in international publication
Authors: Berg, Paul H; Hundemer, Hans P; Khanna, Rashna; Krege, John H; Kudrow, David; Ossipov, Michael H; Pozo-Rosich, Patricia et al.
DOI: 10.1111/head.13731

Italian consensus on treatment of spasticity in multiple sclerosis.

PMID: 31652369
Journal: EUROPEAN JOURNAL OF NEUROLOGY
Year: 2020
Reference: Eur J Neurol. 2020 Mar;27(3):445-453. doi: 10.1111/ene.14110. Epub 2019 Dec 3.
Impact factor: 4.516
Publication type: Paper in international publication
Authors: Comi, G, Solari, A, Leocani, L, Centonze, D, Otero-Romero, S, Amadeo, Roberta, Amato, Maria Pia, Bertolotto, Antonio, Boffa, Laura, Brichetto, Giampaolo et al.
DOI: 10.1111/ene.14110

Italian consensus on treatment of spasticity in multiple sclerosis.

PMID: 31652369
Journal: EUROPEAN JOURNAL OF NEUROLOGY
Year: 2020
Reference: Eur J Neurol. 2020 Mar;27(3):445-453. doi: 10.1111/ene.14110. Epub 2019 Dec 3.
Impact factor:
Publication type: Paper in international publication
Authors: Amadeo, Roberta; Amato, Maria Pia; Bertolotto, Antonio; Boffa, Laura; Brichetto, Giampaolo; Centonze, D; Comi, G; Comola, Mauro; Ghezzi, Angelo; Leocani, L et al.
DOI: 10.1111/ene.14110

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells.

PMID: 32848136
Journal: Nature Communications
Year: 2020
Reference: Nat Commun. 2020 Aug 26;11(1):4261. doi: 10.1038/s41467-020-18081-9.
Impact factor: 12.121
Publication type: Paper in international publication
Authors: Fuentes, Pedro, Sese, Marta, Guijarro, Pedro J, Emperador, Marta, Sanchez-Redondo, Sara, Peinado, Hector, Hummer, Stefan, Ramon Y Cajal, Santiago et al.
DOI: 10.1038/s41467-020-18081-9

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells.

PMID: 32848136
Journal: Nature Communications
Year: 2020
Reference: Nat Commun. 2020 Aug 26;11(1):4261. doi: 10.1038/s41467-020-18081-9.
Impact factor:
Publication type: Paper in international publication
Authors: Emperador, Marta; Fuentes, Pedro; Guijarro, Pedro J; Hummer, Stefan; Peinado, Hector; Ramon Y Cajal, Santiago; Sanchez-Redondo, Sara; Sese, Marta et al.
DOI: 10.1038/s41467-020-18081-9

iTRAQ-based proteomic analysis reveals potential serum biomarkers of allergic and non-allergic asthma.

PMID: 32424932
Journal: ALLERGY
Year: 2020
Reference: Allergy. 2020 Dec;75(12):3171-3183. doi: 10.1111/all.14406. Epub 2020 Jul 3.
Impact factor: 8.706
Publication type: Paper in international publication
Authors: Salgado, Francisco Javier, Nieto-Fontarigo, Juan Jose, Gonzalez-Barcala, Francisco Javier, Andrade-Bulos, Luis Juan, San-Jose, Maria Esther, Cruz, Maria Jesus, Valdes-Cuadrado, Luis, Crujeiras, Rosa Maria, Arias, Pilar et al.
DOI: 10.1111/all.14406

iTRAQ-based proteomic analysis reveals potential serum biomarkers of allergic and non-allergic asthma.

PMID: 32424932
Journal: ALLERGY
Year: 2020
Reference: Allergy. 2020 Dec;75(12):3171-3183. doi: 10.1111/all.14406. Epub 2020 Jul 3.
Impact factor:
Publication type: Paper in international publication
Authors: Andrade-Bulos, Luis Juan; Arias, Pilar; Crujeiras, Rosa Maria; Cruz, Maria Jesus; Gonzalez-Barcala, Francisco Javier; Nieto-Fontarigo, Juan Jose; Salgado, Francisco Javier; San-Jose, Maria Esther; Valdes-Cuadrado, Luis et al.
DOI: 10.1111/all.14406

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.

PMID: 32416072
Journal: LANCET ONCOLOGY
Year: 2020
Reference: Lancet Oncol. 2020 Jun;21(6):796-807. doi: 10.1016/S1470-2045(20)30157-1. Epub 2020 May 13.
Impact factor: 33.752
Publication type: Paper in international publication
Authors: Wu, Bin, Chamberlain, Christina X, Jiang, Liewen, Gliser, Camelia, Pandya, Shuchi S, Valle, Juan W, Zhu, Andrew X, Fan, Bin, El-Khoueiry, Anthony B, Shroff, Rachna T et al.
DOI: 10.1016/S1470-2045(20)30157-1

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.

PMID: 32416072
Journal: LANCET ONCOLOGY
Year: 2020
Reference: Lancet Oncol. 2020 Jun;21(6):796-807. doi: 10.1016/S1470-2045(20)30157-1. Epub 2020 May 13.
Impact factor:
Publication type: Paper in international publication
Authors: Abou-Alfa, Ghassan K; Adeva, Jorge; Borad, Mitesh J; Bridgewater, John; Catenacci, Daniel V; Chamberlain, Christina X; Cleary, James M; El-Khoueiry, Anthony B; Fan, Bin; Gliser, Camelia et al.
DOI: 10.1016/S1470-2045(20)30157-1

JNJ-56136379, an HBV Capsid Assembly Modulator, is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients with Chronic Infection.

PMID: 32343960
Journal: GASTROENTEROLOGY
Year: 2020
Reference: Gastroenterology. 2020 Aug;159(2):521-533.e9. doi: 10.1053/j.gastro.2020.04.036. Epub 2020 Apr 25.
Impact factor: 17.373
Publication type: Paper in international publication
Authors: Zoulim, Fabien, Lenz, Oliver, Vandenbossche, Joris J, Talloen, Willem, Verbinnen, Thierry, Moscalu, Iurie, Bourgeois, Stefan, Buti, Maria, Crespo, Javier, Pascasio, Juan Manuel et al.
DOI: 10.1053/j.gastro.2020.04.036

JNJ-56136379, an HBV Capsid Assembly Modulator, is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients with Chronic Infection.

PMID: 32343960
Journal: GASTROENTEROLOGY
Year: 2020
Reference: Gastroenterology. 2020 Aug;159(2):521-533.e9. doi: 10.1053/j.gastro.2020.04.036. Epub 2020 Apr 25.
Impact factor:
Publication type: Paper in international publication
Authors: Bourgeois, Stefan; Buti, Maria; Crespo, Javier; Fry, John; Lenz, Oliver; Moscalu, Iurie; Pascasio, Juan Manuel; Sarrazin, Christoph; Shukla, Umesh; Streinu-Cercel, Adrian et al.
DOI: 10.1053/j.gastro.2020.04.036

JSCO/ESMO/ASCO/JSMO/TOS: International expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions.

PMID: 32272210
Journal: ANNALS OF ONCOLOGY
Year: 2020
Reference: Ann Oncol. 2020 Jul;31(7):861-872. doi: 10.1016/j.annonc.2020.03.299. Epub 2020 Apr 6.
Impact factor: 18.274
Publication type: Paper in international publication
Authors: Yoshino, T, Pentheroudakis, G, Mishima, S, Overman, M J, Yeh, K-H, Baba, E, Naito, Y, Calvo, F, Saxena, A, Chen, L-T et al.
DOI: 10.1016/j.annonc.2020.03.299

JSCO/ESMO/ASCO/JSMO/TOS: International expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions.

PMID: 32272210
Journal: ANNALS OF ONCOLOGY
Year: 2020
Reference: Ann Oncol. 2020 Jul;31(7):861-872. doi: 10.1016/j.annonc.2020.03.299. Epub 2020 Apr 6.
Impact factor:
Publication type: Paper in international publication
Authors: Baba, E; Burris, H; Calvo, F; Cervantes, A; Chen, L-T; Douillard, J-Y; Kitagawa, Y; Kodera, Y; Mishima, S; Naito, Y et al.
DOI: 10.1016/j.annonc.2020.03.299

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.

PMID: 31066634
Journal: Multiple Sclerosis Journal
Year: 2020
Reference: Mult Scler. 2020 Jul;26(8):912-923. doi: 10.1177/1352458519845844. Epub 2019 May 8.
Impact factor: 5.412
Publication type: Paper in international publication
Authors: Hegen, H, Leurs, C E, Twaalfhoven, Ham, Lissenberg-Witte, B I, van Pesch, V, Dujmovic, I, Drulovic, J, Castellazzi, M, Bellini, T, Pugliatti, M et al.
DOI: 10.1177/1352458519845844

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.

PMID: 31066634
Journal: Multiple Sclerosis Journal
Year: 2020
Reference: Mult Scler. 2020 Jul;26(8):912-923. doi: 10.1177/1352458519845844. Epub 2019 May 8.
Impact factor:
Publication type: Paper in international publication
Authors: Altintas, A; Alvarez-Cermeno, J C; Alvarez-Lafuente, R; Bellini, T; Bridel, C; Castellazzi, M; Comabella, M; Deisenhammer, F; Drulovic, J; Dujmovic, I et al.
DOI: 10.1177/1352458519845844

Keeping standards of multiple sclerosis care through the COVID-19 pandemic.

PMID: 32552382
Journal: Multiple Sclerosis Journal
Year: 2020
Reference: Mult Scler. 2020 Sep;26(10):1153-1156. doi: 10.1177/1352458520931785. Epub 2020 Jun 19.
Impact factor: 5.412
Publication type: Editorail in international publication
Authors: Sastre-Garriga, Jaume, Tintore, Mar, Montalban, Xavier et al.
DOI: 10.1177/1352458520931785

Keeping standards of multiple sclerosis care through the COVID-19 pandemic.

PMID: 32552382
Journal: Multiple Sclerosis Journal
Year: 2020
Reference: Mult Scler. 2020 Sep;26(10):1153-1156. doi: 10.1177/1352458520931785. Epub 2020 Jun 19.
Impact factor:
Publication type: Editorail in international publication
Authors: Montalban, Xavier; Sastre-Garriga, Jaume; Tintore, Mar et al.
DOI: 10.1177/1352458520931785

Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.

PMID: 32669323
Journal: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Year: 2020
Reference: J Am Soc Nephrol. 2020 Sep;31(9):1941-1943. doi: 10.1681/ASN.2020050667. Epub 2020 Jul 15.
Impact factor: 9.274
Publication type: Letter whit IF
Authors: Wysocki, Jan, Lores, Enrique, Ye, Minghao, Soler, Maria Jose, Batlle, Daniel et al.
DOI: 10.1681/ASN.2020050667

Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.

PMID: 32669323
Journal: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Year: 2020
Reference: J Am Soc Nephrol. 2020 Sep;31(9):1941-1943. doi: 10.1681/ASN.2020050667. Epub 2020 Jul 15.
Impact factor:
Publication type: Letter whit IF
Authors: Batlle, Daniel; Lores, Enrique; Soler, Maria Jose; Wysocki, Jan; Ye, Minghao et al.
DOI: 10.1681/ASN.2020050667

Kidney cancer PDOXs reveal patient-specific pro-malignant effects of antiangiogenics and its molecular traits.

PMID: 33151035
Journal: EMBO Molecular Medicine
Year: 2020
Reference: EMBO Mol Med. 2020 Dec 7;12(12):e11889. doi: 10.15252/emmm.201911889. Epub 2020 Nov 5.
Impact factor: 8.821
Publication type: Paper in international publication
Authors: Moserle, Lidia, Pons, Roser, Martinez-Lozano, Mar, Jimenez-Valerio, Gabriela A, Vidal, August, Suarez, Cristina, Trilla, Enrique, Jimenez, Jose, de Torres, Ines, Carles, Joan et al.
DOI: 10.15252/emmm.201911889

Kidney cancer PDOXs reveal patient-specific pro-malignant effects of antiangiogenics and its molecular traits.

PMID: 33151035
Journal: EMBO Molecular Medicine
Year: 2020
Reference: EMBO Mol Med. 2020 Dec 7;12(12):e11889. doi: 10.15252/emmm.201911889. Epub 2020 Nov 5.
Impact factor:
Publication type: Paper in international publication
Authors: Aguilar, Susana; Amadori, Alberto; Carles, Joan; Casanovas, Oriol; de Torres, Ines; Jimenez, Jose; Jimenez-Valerio, Gabriela A; Martinez-Lozano, Mar; Moserle, Lidia; Palomero, Luis et al.
DOI: 10.15252/emmm.201911889

Publications

Publications searcher

Isolated cerebral mucormycosis associated with intravenous drug use.

Isolated cerebral mucormycosis associated with intravenous drug use.

Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan.

Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan.

Italian consensus on treatment of spasticity in multiple sclerosis.

Italian consensus on treatment of spasticity in multiple sclerosis.

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells.

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells.

iTRAQ-based proteomic analysis reveals potential serum biomarkers of allergic and non-allergic asthma.

iTRAQ-based proteomic analysis reveals potential serum biomarkers of allergic and non-allergic asthma.

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.

JNJ-56136379, an HBV Capsid Assembly Modulator, is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients with Chronic Infection.

JNJ-56136379, an HBV Capsid Assembly Modulator, is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients with Chronic Infection.

JSCO/ESMO/ASCO/JSMO/TOS: International expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions.

JSCO/ESMO/ASCO/JSMO/TOS: International expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions.

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.

Keeping standards of multiple sclerosis care through the COVID-19 pandemic.

Keeping standards of multiple sclerosis care through the COVID-19 pandemic.

Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.

Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.

Kidney cancer PDOXs reveal patient-specific pro-malignant effects of antiangiogenics and its molecular traits.

Kidney cancer PDOXs reveal patient-specific pro-malignant effects of antiangiogenics and its molecular traits.

Patronage:

Collaborating:

Accreditations: